# Defining the Molecular and Physiological Mechanisms of Pancreatic Islet Cell Dysfunction Which Lead to Type 2 Diabetes

> **NCT02505308** · NA · COMPLETED · sponsor: **Royal Devon and Exeter NHS Foundation Trust** · enrollment: 328 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **OTHER:** Glucose-Potentiated Arginine-Induced Insulin Secretion

## Key facts

- **NCT ID:** NCT02505308
- **Lead sponsor:** Royal Devon and Exeter NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-04
- **Primary completion:** 2019-03-31
- **Final completion:** 2019-08-31
- **Target enrollment:** 328 (ACTUAL)
- **Last updated:** 2019-09-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02505308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02505308, "Defining the Molecular and Physiological Mechanisms of Pancreatic Islet Cell Dysfunction Which Lead to Type 2 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02505308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*